Decitabine combined with minimally myelosuppressive therapy for induction of remission in pediatric high-risk acute myeloid leukemia with chromosome 5q deletion: a report of three cases-MedSci.cn

Decitabine combined with minimally myelosuppressive therapy for induction of remission in pediatric high-risk acute myeloid leukemia with chromosome 5q deletion: a report of three cases

Cheng, SQ; Xiao, PF; Wang, JX; Li, ZH; Gao, L; Zheng, JJ; Hu, YX; Ding, X; Ling, J; Lu, Q; Pan, J; Li, BH; Lu, J; Wang, Y; Ribeiro, RC; Hu, SY

Hu, SY (通讯作者)，Soochow Univ, Childrens Hosp, Dept Hematol & Oncol, Suzhou Ind Pk, 92 Zhongnan St, Suzhou 215025, Peoples R China.;Ribeiro, RC (通讯作者)，St Jude Childrens Res Hosp, Div Leukemia Lymphoma, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA.;Ribeiro, RC (通讯作者)，St Jude Childrens Res Hosp, Dept Global Pediat Med, 332 N Lauderdale St, Memphis, TN 38105 USA.

Abstract

Cases of pediatric acute myeloid leukemia (AML) with complex karyotypes including chromosome 5 abnormalities are rare and have a very poor prognosis. ......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Decitabine combined with minimally myelosuppressive therapy for induction of remission in pediatric high-risk acute myeloid leukemia with chromosome 5q deletion: a report of three cases

科室

工具

服务